Evaluation of efficacy and safety of Dabigatran in patients with catheter ablation for atrial fibrillation.

Trial Profile

Evaluation of efficacy and safety of Dabigatran in patients with catheter ablation for atrial fibrillation.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs Dabigatran etexilate (Primary) ; Warfarin
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 27 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top